Skip to main content

Table 2 Predictive factors for the emergence of EGFR-T790M mutation according to multivariate analysis

From: The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations

Variables

Odds ratio

p value

Histology

 Adenocarcinoma (vs. other)

0.35 (0.06–2.05)

0.24

EGFR mutation status

 Exon 19 deletion (vs. other)

0.52 (0.20–1.37)

0.18

MTS

 The levels of shrinkage

1.03 (1.00–1.05)

0.023

PFS duration

  > =6 months (vs. < 6 months)

2.43 (0.54–11.00)

0.25

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us